Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-19 Sale |
2021-11-19 10:20 am |
Flexion Therapeutics Inc | FLXN | Stejbach Mark Director |
12,631 | $8.5 | $107,364 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:19 am |
Flexion Therapeutics Inc | FLXN | MILINAZZO ALAN Director |
27,450 | $8.5 | $233,325 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:17 am |
Flexion Therapeutics Inc | FLXN | MERRIFIELD C ANN Director |
19,000 | $8.5 | $161,500 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:16 am |
Flexion Therapeutics Inc | FLXN | Lukatch Heath Director |
9,000 | $8.5 | $76,500 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:14 am |
Flexion Therapeutics Inc | FLXN | Kwo Elizabeth Director |
4,500 | $8.5 | $38,250 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:12 am |
Flexion Therapeutics Inc | FLXN | COLELLA SAMUEL D Director |
1,496,564 | $8.5 | $12,720,794 | 0 (Indirect Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:10 am |
Flexion Therapeutics Inc | FLXN | Canute Scott A Director |
9,000 | $8.5 | $76,500 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:09 am |
Flexion Therapeutics Inc | FLXN | MAHAFFY PATRICK J Director |
39,824 | $8.5 | $338,504 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:08 am |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
133,486 | $8.5 | $1,134,631 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:06 am |
Flexion Therapeutics Inc | FLXN | Muzikant Adam Chief Business Officer |
103,666 | $8.5 | $881,161 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:04 am |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
146,843 | $8.5 | $1,248,166 | 0 (Indirect Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:03 am |
Flexion Therapeutics Inc | FLXN | Layman Melissa Chief Commercial Officer |
103,956 | $8.5 | $883,626 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:01 am |
Flexion Therapeutics Inc | FLXN | Willwerth Christina Chief Strategy Officer |
141,241 | $8.5 | $1,200,549 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 10:00 am |
Flexion Therapeutics Inc | FLXN | DRISCOLL FREDERICK W Chief Financial Officer |
30,680 | $8.5 | $260,780 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 09:58 am |
Flexion Therapeutics Inc | FLXN | Andrews William T. Chief Medical Officer |
34,250 | $8.5 | $291,125 | 0 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-19 09:56 am |
Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO |
1,122,550 | $8.5 | $9,541,675 | 0 (Indirect Direct) |
View |
| 2021-07-19 Sale |
2021-07-20 8:51 pm |
Flexion Therapeutics Inc | FLXN | Willwerth Christina Chief Strategy Officer |
3,945 | $6.45 | $25,445 | 141,241 (Direct) |
View |
| 2021-07-19 Sale |
2021-07-20 8:49 pm |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
3,944 | $6.45 | $25,439 | 146,362 (Indirect Direct) |
View |
| 2021-07-19 Sale |
2021-07-20 8:48 pm |
Flexion Therapeutics Inc | FLXN | Muzikant Adam Chief Business Officer |
1,870 | $6.45 | $12,062 | 103,666 (Direct) |
View |
| 2021-07-19 Sale |
2021-07-20 8:45 pm |
Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel |
3,945 | $6.45 | $25,445 | 133,486 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-11-19 Equity Swap |
2021-11-23 7:00 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Newtyn Management LLC 10% Owner |
5,900,000 | $0 | 0 (Indirect) |
View |
Ownership |
2021-11-23 6:57 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Newtyn Management LLC 10% Owner |
0 | $0 | 5,900,000 (Indirect) |
View |
| 2021-08-02 Option Award |
2021-08-04 4:09 pm |
N/A 2031-08-01 |
Flexion Therapeutics Inc | FLXN | Andrews William T. Chief Medical Officer |
239,750 | $0 | 239,750 (Direct) |
View |
| 2021-07-19 Tax Withholding |
2021-07-20 8:44 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO |
13,859 | $0 | 1,122,033 (Direct) |
View |
| 2021-07-09 Option Award |
2021-07-12 4:06 pm |
N/A 2031-07-08 |
Flexion Therapeutics Inc | FLXN | Koppikar Utpal Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:42 pm |
N/A 2031-06-23 |
Flexion Therapeutics Inc | FLXN | Kwo Elizabeth Director |
11,500 | $0 | 11,500 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:40 pm |
N/A 2031-06-23 |
Flexion Therapeutics Inc | FLXN | MERRIFIELD C ANN Director |
11,500 | $0 | 26,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:38 pm |
N/A 2031-06-23 |
Flexion Therapeutics Inc | FLXN | Canute Scott A Director |
11,500 | $0 | 16,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:32 pm |
N/A 2031-06-23 |
Flexion Therapeutics Inc | FLXN | COLELLA SAMUEL D Director |
11,500 | $0 | 1,503,564 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:30 pm |
N/A 2031-06-23 |
Flexion Therapeutics Inc | FLXN | Stejbach Mark Director |
11,500 | $0 | 19,631 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:25 pm |
N/A 2031-06-23 |
Flexion Therapeutics Inc | FLXN | Lukatch Heath Director |
11,500 | $0 | 16,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:24 pm |
N/A 2031-06-23 |
Flexion Therapeutics Inc | FLXN | MAHAFFY PATRICK J Director |
17,000 | $0 | 52,324 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:16 pm |
N/A 2031-06-23 |
Flexion Therapeutics Inc | FLXN | MILINAZZO ALAN Director |
11,500 | $0 | 34,450 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-28 6:13 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Muzikant Adam Chief Business Officer |
2,081 | $7.78 | 105,536 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-28 6:09 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
539 | $7.78 | 150,306 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-28 6:04 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO |
1,700 | $7.78 | 1,135,892 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 4:20 pm |
N/A 2031-05-31 |
Flexion Therapeutics Inc | FLXN | DRISCOLL FREDERICK W Chief Financial Officer |
196,000 | $0 | 198,680 (Direct) |
View |